Akebia Therapeutics
AKBA
#7044
Rank
A$0.61 B
Marketcap
$2.80
Share price
1.68%
Change (1 day)
85.68%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -A$62.07 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are A$0.17 Billion. In 2023 the company made an earning of -A$79.96 Million, an increase over its 2022 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$62.07 Million-22.38%
2023 -A$79.96 Million-45.12%
2022 -A$0.15 Billion-66.55%
2021 -A$0.44 Billion-26.24%
2020 -A$0.6 Billion33.94%
2019 -A$0.45 Billion66.52%
2018 -A$0.27 Billion123.53%
2017 -A$0.12 Billion-43.34%
2016 -A$0.21 Billion123.58%
2015 -A$93.5 Million63.95%
2014 -A$57.03 Million181.24%
2013 -A$20.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.20 B-11,669.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.60 B-31,582.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$28.32 B-45,584.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.28 Billion 338.06%๐Ÿ‡บ๐Ÿ‡ธ USA